Scarica l'app Stockscreener
82.47
3.18%
2.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
DexCom (DXCM) to Launch Dexcom G7 15 Day CGM System in Canada Ne - GuruFocus
Dexcom launches 15-day glucose monitor in Canada next month By Investing.com - Investing.com India
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in NovemberDexCom, Inc. - DexCom, Inc. - Investor Relations
Dexcom G7 15 Day glucose monitor to launch in Canada in November - StreetInsider
What to expect from DexCom’s (DXCM) Q3 earnings - Yahoo Finance
Here’s How Much You Would Have Made Owning DexCom Stock In The Last 15 Years - Benzinga
Our Dexcom Pick Had a Minor Setback. It’s Still a Diabetes Winner. - Barron's
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Is DexCom (DXCM) Cheap After CONNECT Trial Results Backed G7 Adoption? - Simply Wall Street
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - Zacks Investment Research
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - Zacks Investment Research
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - TradingView
Leerink Partners Adjusts Price Target on DexCom to $87 From $94 - marketscreener.com
Dexcom Inc Lobbying Profile, 2020 - OpenSecrets
Form 144 DEXCOM For: 26 October By Investing.com - Investing.com Nigeria
DexCom, Inc. (DXCM) Options ChainYahoo Finance - Yahoo! Finance Canada
DexCom, Inc. Estimates – NASDAQ:DXCM - TradingView
Why Is DexCom (DXCM) In Focus After Its G7 Trial Reached NEJM? - Yahoo Finance
DexCom Inc (DXCM) Shares Fall 6.4% -- What GF Score of 95 Tells Investors - GuruFocus
Precision Trading with Dexcom Inc. (DXCM) Risk Zones - Stock Traders Daily
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom (DXCM) Shares Fall 6.5% Amid Broader Market Gains on Octo - GuruFocus
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers - ChartMill
Global Digital Health and Remote Patient Monitoring Strategic Market Report, 2026-2031 | 20.2% CAGR to $80.8 Billion as Connected Care and Wearables Scale - GlobeNewswire Inc.
DexCom Inc. Company & People | DXCM.USD - Barron's
DXCM.USD | DexCom Inc. Stock Overview (Switzerland: SWX) - Barron's
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study - Zacks Investment Research
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study - Yahoo! Finance Canada
Form 4 DexCom Inc: Michael Jon Brown (EVP Chief Legal Compliance Off) For: 15 October By Investing.com - Investing.com South Africa
Dexcom EVP Michael Brown sells $145,316 in company stock - Investing.com
Dexcom class action lawsuits claim ShinyHunters stole health data - Top Class Actions
DexCom: The 15-Day Sensor Lowered The Cost Curve Before The Type 2 Wave Arrives - Seeking Alpha
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Dexcom faces a class action over an alleged data breach that ShinyHunters claimed responsibility for. - Claim Depot
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - TradingView
Vaso Stock Surges 149% in a Year: What's Behind the Rally? - Zacks Investment Research
A Look at DexCom Inc (DXCM) After 5.1% Gain -- GF Value $103.59 vs Price $87.71 - GuruFocus
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom gains as NEJM publication boosts Medicare coverage hopes - TradingView
Landmark Dexcom CONNECT Study Published in The New England Journ - GuruFocus
Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin - Dexcom
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DexCom Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Yahoo Finance
DexCom (NASDAQ:DXCM): Affordable Growth at a Reasonable Valuation - ChartMill
Here's What to Expect From DexCom’s Next Earnings Report - inkl
Here's What to Expect From DexCom’s Next Earnings Report - Yahoo Finance
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
0.30%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):